Tolerability and Efficacy of Midostaurin to 10-day Decitabine in Unfit Adult AML and High Risk MDS Patients

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Tolerability and Efficacy of Midostaurin to 10-day Decitabine in Unfit Adult AML and High Risk MDS Patients	AML/MDS	Active, not recruiting	Phase 2	2024-09-19		NCT04097470

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Stichting Hemato-Oncologie voor Volwassenen Nederland	27
Swiss Cancer Institute	29

37 results · Page 1 of 2

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
BE-Antwerpen-ZNASTUIVENBERG	Antwerp	Belgium	8
BE-Haine-Saint-Paul-JOLIMONT	Haine-Saint-Paul	Belgium	3
BE-Roeselare-AZDELTA	Roeselare	Belgium	7
CH-Aarau-KSA	Aarau	Switzerland	3
CH-Basel-USB	Basel	Switzerland	5
CH-Bellinzona-IOSI	Bellinzona	Switzerland	5
CH-Bern-INSEL	Bern	Switzerland	6
CH-Fribourg-HFR	Fribourg	Switzerland	4
CH-Geneve (14)-HCUGE	Geneva	Switzerland	5
CH-Lausanne-CHUV	Lausanne	Switzerland	2
CH-Luzern-LUKS	Lucerne	Switzerland	3
CH-St. Gallen-KSSG	Sankt Gallen	Switzerland	4
CH-Zürich-USZ	Zurich	Switzerland	5
DE-Magdeburg-OVGU	Magdeburg	Germany	4
NL-Amersfoort-MEANDERMC	Amersfoort	Netherlands	13
NL-Amsterdam-OLVG	Amsterdam	Netherlands	8
NL-Amsterdam-VUMC	Amsterdam	Netherlands	10
NL-Arnhem-RIJNSTATE	Arnhem	Netherlands	11
NL-Breda-AMPHIA	Breda	Netherlands	10
NL-Delft-RDGG	Delft	Netherlands	8
NL-Den Bosch-JBZ	's-Hertogenbosch	Netherlands	14
NL-Den Haag-HAGA	The Hague	Netherlands	13
NL-Doetinchem-Slingeland	Doetinchem	Netherlands	2
NL-Dordrecht-ASZ	Dordrecht	Netherlands	14
NL-Ede-ZGV	Ede	Netherlands	6

Clinical trials